
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5238474
[patent_doc_number] => 20070130631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'TAAR1 transgenic animal'
[patent_app_type] => utility
[patent_app_number] => 11/602010
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6823
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20070130631.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602010 | TAAR1 transgenic animal | Nov 19, 2006 | Abandoned |
Array
(
[id] => 5210158
[patent_doc_number] => 20070248742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Transgenic aquatic invertebrates as a bioreactor for production of recombinant polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/601613
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15731
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601613 | Transgenic aquatic invertebrates as a bioreactor for production of recombinant polypeptides | Nov 15, 2006 | Abandoned |
Array
(
[id] => 5212356
[patent_doc_number] => 20070250940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Transgenic mice for bioassay of prions from deer and elk with chronic wasting disease'
[patent_app_type] => utility
[patent_app_number] => 11/598086
[patent_app_country] => US
[patent_app_date] => 2006-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10643
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20070250940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11598086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/598086 | Transgenic mice for bioassay of prions from deer and elk with chronic wasting disease | Nov 12, 2006 | Abandoned |
Array
(
[id] => 9621150
[patent_doc_number] => 08791323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse'
[patent_app_type] => utility
[patent_app_number] => 11/595427
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 13160
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11595427
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595427 | Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse | Nov 8, 2006 | Issued |
Array
(
[id] => 5370225
[patent_doc_number] => 20090307784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Methods of Analysing Cell Behaviour'
[patent_app_type] => utility
[patent_app_number] => 12/090464
[patent_app_country] => US
[patent_app_date] => 2006-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16947
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0307/20090307784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090464 | Methods of Analysing Cell Behaviour | Oct 19, 2006 | Abandoned |
Array
(
[id] => 5539878
[patent_doc_number] => 20090221683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 12/090046
[patent_app_country] => US
[patent_app_date] => 2006-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16729
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221683.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090046 | Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis | Oct 17, 2006 | Abandoned |
Array
(
[id] => 10070701
[patent_doc_number] => 09109045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Mass producing growth factor using adipose derived adult stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/161899
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 13851
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12161899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161899 | Mass producing growth factor using adipose derived adult stem cells | Oct 11, 2006 | Issued |
Array
(
[id] => 7987671
[patent_doc_number] => 08076130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Plasmid maintenance system for antigen delivery'
[patent_app_type] => utility
[patent_app_number] => 11/542264
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 42
[patent_no_of_words] => 38125
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076130.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542264
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542264 | Plasmid maintenance system for antigen delivery | Oct 3, 2006 | Issued |
Array
(
[id] => 5277930
[patent_doc_number] => 20090130062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Novel Application of Heparin-Binding Epidermal Growth Factor-Like Growth Factor for Medical Purposes'
[patent_app_type] => utility
[patent_app_number] => 11/992728
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17151
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992728
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992728 | Application of heparin-binding epidermal growth factor-like growth factor for medical purposes | Sep 27, 2006 | Issued |
Array
(
[id] => 5182956
[patent_doc_number] => 20070054303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Expression Vectors and Methods'
[patent_app_type] => utility
[patent_app_number] => 11/535003
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 24021
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535003 | Expression Vectors and Methods | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5315945
[patent_doc_number] => 20090280543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'REGIOSELECTIVE GLYCOSYLATION'
[patent_app_type] => utility
[patent_app_number] => 12/067526
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10354
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280543.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067526 | REGIOSELECTIVE GLYCOSYLATION | Sep 20, 2006 | Abandoned |
Array
(
[id] => 5106544
[patent_doc_number] => 20070065421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Inducing expression of puma to reduce joint inflammation in the treatment of arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/522026
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11726
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065421.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522026 | Inducing expression of puma to reduce joint inflammation in the treatment of arthritis | Sep 14, 2006 | Abandoned |
Array
(
[id] => 4658156
[patent_doc_number] => 20080027018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Electrotransfer of nucleic acid into tissue cells'
[patent_app_type] => utility
[patent_app_number] => 11/514354
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7931
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11514354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/514354 | Electrotransfer of nucleic acid into tissue cells | Aug 31, 2006 | Issued |
Array
(
[id] => 5226882
[patent_doc_number] => 20070256149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Dep2 and its uses in major depressive disorder and other related disorders'
[patent_app_type] => utility
[patent_app_number] => 11/509296
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 107
[patent_figures_cnt] => 107
[patent_no_of_words] => 37768
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 56
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11509296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/509296 | Dep2 and its uses in major depressive disorder and other related disorders | Aug 23, 2006 | Issued |
Array
(
[id] => 7728494
[patent_doc_number] => 08101169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-24
[patent_title] => 'Ocular gene therapy using avalanche-mediated transfection'
[patent_app_type] => utility
[patent_app_number] => 11/505249
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6931
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/101/08101169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11505249
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/505249 | Ocular gene therapy using avalanche-mediated transfection | Aug 14, 2006 | Issued |
Array
(
[id] => 5370231
[patent_doc_number] => 20090307790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/997992
[patent_app_country] => US
[patent_app_date] => 2006-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25769
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0307/20090307790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997992
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997992 | ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF | Aug 11, 2006 | Abandoned |
Array
(
[id] => 5608518
[patent_doc_number] => 20060270034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Methods of culturing embryonic stem cells and controlled differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/499219
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9179
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270034.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499219
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499219 | Methods of culturing embryonic stem cells and controlled differentiation | Aug 3, 2006 | Abandoned |
Array
(
[id] => 5215614
[patent_doc_number] => 20070104695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Breast augmentation and reconstruction system'
[patent_app_type] => utility
[patent_app_number] => 11/490431
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490431 | Breast augmentation and reconstruction system | Jul 19, 2006 | Abandoned |
Array
(
[id] => 4875057
[patent_doc_number] => 20080201791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells'
[patent_app_type] => utility
[patent_app_number] => 11/917842
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5044
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20080201791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917842 | T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells | Jun 26, 2006 | Abandoned |
Array
(
[id] => 4994668
[patent_doc_number] => 20070010013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Oocytes derived from ovarian culture initially containing no oocytes'
[patent_app_type] => utility
[patent_app_number] => 11/473910
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5382
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010013.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473910 | Oocytes derived from ovarian culture initially containing no oocytes | Jun 22, 2006 | Issued |